Intracellular stress signaling pathways activated during human islet preparation and following acute cytokine exposure

被引:146
作者
Abdelli, S
Ansite, J
Roduit, R
Borsello, T
Matsumoto, I
Sawada, T
Allaman-Pillet, N
Henry, H
Beckmann, JS
Hering, BJ
Bonny, C
机构
[1] Serv Med Genet, Lausanne, Switzerland
[2] Univ Minnesota, Diabet Inst Immunol & Transplantat, Minneapolis, MN 55455 USA
[3] Univ Hosp Falaises, Lausanne, Switzerland
关键词
D O I
10.2337/diabetes.53.11.2815
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Pancreatic islet transplantation may successfully restore normoglycemia in type 1 diabetic patients. However, successful grafting requires transplantation of a sufficient number of islets, usually requiring two or more donors. During the isolation process and following clinical transplantation, islets are subjected to severe adverse conditions that impair survival and ultimately contribute to graft failure. Here, we have mapped the major intracellular stress-signaling pathways that may mediate human islet loss during isolation and following cytokine attack. We found that the isolation procedure potently recruits two pathways consisting of \mitogen-activated protein kinase kinase (MKK)7 --> Jun NH2-terminal kinase (JNK)/p38 --> c-fos\ and the \nuclear factor-kappaB (NF-kappaB) - iNOS\ module. Cytokines activate the \NF-kappaB --> iNOS\ and \MKK4/MKK3/6 --> JNK/p38\ pathways without recruitment of c-fos. Culturing the islets for 48 h after isolation allows for the activated pathways to return to background levels, with expression of MKK7 becoming undetectable. These data indicate that isolation and cytokines recruit different death pathways. Therefore, strategies might be rationally developed to avoid possible synergistic activation of these pathways in mediating islet loss during isolation and following grafting.
引用
收藏
页码:2815 / 2823
页数:9
相关论文
共 59 条
  • [1] The c-Jun amino-terminal kinase pathway is preferentially activated by interleukin-1 and controls apoptosis in differentiating pancreatic β-cells
    Ammendrup, A
    Maillard, A
    Nielsen, K
    Andersen, NA
    Serup, P
    Madsen, OD
    Mandrup-Poulsen, T
    Bonny, C
    [J]. DIABETES, 2000, 49 (09) : 1468 - 1476
  • [2] INTERLEUKIN-1 BETA-INDUCED NITRIC-OXIDE PRODUCTION ACTIVATES APOPTOSIS IN PANCREATIC RINM5F CELLS
    ANKARCRONA, M
    DYPBUKT, JM
    BRUNE, B
    NICOTERA, P
    [J]. EXPERIMENTAL CELL RESEARCH, 1994, 213 (01) : 172 - 177
  • [3] I-KAPPA-B - A SPECIFIC INHIBITOR OF THE NF-KAPPA-B TRANSCRIPTION FACTOR
    BAEUERLE, PA
    BALTIMORE, D
    [J]. SCIENCE, 1988, 242 (4878) : 540 - 546
  • [4] Expression of a dominant negative inhibitor of NF-κB protects MIN6 β-cells from cytokine-induced apoptosis
    Baker, MS
    Chen, XJ
    Cao, XC
    Kaufman, DB
    [J]. JOURNAL OF SURGICAL RESEARCH, 2001, 97 (02) : 117 - 122
  • [5] CELL-MEDIATED AUTOIMMUNITY IN TYPE-I DIABETES
    BARBOSA, J
    BACH, FH
    [J]. DIABETES-METABOLISM REVIEWS, 1987, 3 (04): : 981 - 1004
  • [6] Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death
    Bonny, C
    Oberson, A
    Negri, S
    Sauser, C
    Schorderet, DF
    [J]. DIABETES, 2001, 50 (01) : 77 - 82
  • [7] ERKS - A FAMILY OF PROTEIN-SERINE THREONINE KINASES THAT ARE ACTIVATED AND TYROSINE PHOSPHORYLATED IN RESPONSE TO INSULIN AND NGF
    BOULTON, TG
    NYE, SH
    ROBBINS, DJ
    IP, NY
    RADZIEJEWSKA, E
    MORGENBESSER, SD
    DEPINHO, RA
    PANAYOTATOS, N
    COBB, MH
    YANCOPOULOS, GD
    [J]. CELL, 1991, 65 (04) : 663 - 675
  • [8] Mechanism of p38 MAP kinase activation in vivo
    Brancho, D
    Tanaka, N
    Jaeschke, A
    Ventura, JJ
    Kelkar, N
    Tanaka, Y
    Kyuuma, M
    Takeshita, T
    Flavell, RA
    Davis, RJ
    [J]. GENES & DEVELOPMENT, 2003, 17 (16) : 1969 - 1978
  • [9] BRETZEL RG, 1994, DIABETOLOGIA, V37, pA38
  • [10] Brunet A, 1997, ESSAYS BIOCHEM, V32, P1